Skip to content

Effectiveness of trial-based therapy in post-traumatic stress disorder

Effectiveness of trial-based therapy in post-traumatic stress disorder: a randomised clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58151265
Enrollment
72
Registered
2014-06-19
Start date
2014-01-30
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic, subclinical or partial post-traumatic stress disorder Mental and Behavioural Disorders Post-traumatic stress disorder

Interventions

72 patients enrolled in the Anxiety Program and the Psychotherapy Service of the Department and Institute of Psychiatry, University of São Paulo with the diagnosis of chronic PTSD will be invited to p

Sponsors

Anxiety Program (Amban) at the Institute of Psychiatry Faculty of Medicine University of São Paulo (Brazil)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both genders 2. Age 18 and 65 years 3. Able to write and follow the instructions of the protocol 4. Give consent

Exclusion criteria

Exclusion criteria: 1. People with imminent risk of suicide, self-mutilation behaviours (cutting, burning, hurting themselves deliberately) 2. Psychosis not stabilized with medication 3. Risk of suffering further violence 4. Lack of memory about the traumatic event 5. Abuse or dependence of alcohol and drugs

Design outcomes

Primary

MeasureTime frame
An assessment will be carried out with self questionnaires applied prior to initiating therapy after 13 sessions and after 3 months of completion of therapy.This will be used as a criterion of effectiveness a 15 points change in Davidson Trauma Scale according to the literature.

Secondary

MeasureTime frame
1. Changes in scores on the Beck Depression and Anxiety Inventories (BDI and BAI) 2. Clinical Global Impression Scale (CGI) 3. Automatic Thoughts Questionnaire (ATQ 30) 4. Dysfunctional Attitudes Questionnaire (DAS) 5. SF-36 6. Number of treatment drop outs

Countries

Brazil

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026